1 6‐month survival |
30 |
5755 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [1.00, 1.09] |
1.1 Undifferentiated |
10 |
1808 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.94, 1.10] |
1.2 Limited Disease |
8 |
1044 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.94, 1.07] |
1.3 Extensive Disease |
18 |
2903 |
Risk Ratio (M‐H, Random, 95% CI) |
1.09 [1.02, 1.17] |
2 12‐month survival |
31 |
6034 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.97, 1.16] |
2.1 Undifferentiated |
10 |
1808 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.82, 1.22] |
2.2 Limited Disease |
9 |
1209 |
Risk Ratio (M‐H, Random, 95% CI) |
1.15 [0.95, 1.39] |
2.3 Extensive Disease |
19 |
3017 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.94, 1.18] |
3 24‐month survival |
27 |
5398 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.85, 1.31] |
3.1 Undifferentiated |
10 |
1808 |
Risk Ratio (M‐H, Random, 95% CI) |
0.97 [0.71, 1.33] |
3.2 Limited Disease |
9 |
1209 |
Risk Ratio (M‐H, Random, 95% CI) |
1.07 [0.70, 1.65] |
3.3 Extensive Disease |
15 |
2381 |
Risk Ratio (M‐H, Random, 95% CI) |
1.11 [0.71, 1.75] |
4 Overall response |
31 |
5651 |
Risk Ratio (M‐H, Random, 95% CI) |
1.06 [0.98, 1.13] |
4.1 Undifferentiated |
11 |
2225 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.89, 1.21] |
4.2 Limited Disease |
8 |
809 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.94, 1.12] |
4.3 Extensive Disease |
18 |
2617 |
Risk Ratio (M‐H, Random, 95% CI) |
1.07 [0.96, 1.19] |
5 Complete response |
30 |
5599 |
Risk Ratio (M‐H, Random, 95% CI) |
1.32 [1.14, 1.54] |
5.1 Undifferentiated |
10 |
2175 |
Risk Ratio (M‐H, Random, 95% CI) |
1.26 [0.90, 1.77] |
5.2 Limited Disease |
8 |
809 |
Risk Ratio (M‐H, Random, 95% CI) |
1.19 [1.02, 1.40] |
5.3 Extensive Disease |
18 |
2615 |
Risk Ratio (M‐H, Random, 95% CI) |
1.45 [1.17, 1.80] |
6 Toxic Death |
20 |
3696 |
Risk Ratio (M‐H, Random, 95% CI) |
1.08 [0.72, 1.62] |
7 Nausea and Vomiting |
22 |
3961 |
Risk Ratio (M‐H, Random, 95% CI) |
1.52 [1.22, 1.88] |
8 Alopecia |
8 |
1526 |
Risk Ratio (M‐H, Random, 95% CI) |
1.14 [1.00, 1.30] |
9 Infection |
12 |
2184 |
Risk Ratio (M‐H, Random, 95% CI) |
0.69 [0.43, 1.09] |
10 Anaemia |
12 |
2219 |
Risk Ratio (M‐H, Random, 95% CI) |
1.19 [0.86, 1.67] |
11 Leukopenia |
17 |
2556 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.67, 1.05] |
12 Thrombocytopenia |
19 |
3276 |
Risk Ratio (M‐H, Random, 95% CI) |
1.89 [1.37, 2.61] |
12.1 New Subgroup |
19 |
3276 |
Risk Ratio (M‐H, Random, 95% CI) |
1.89 [1.37, 2.61] |
13 Granulocytopenia |
5 |
1229 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.79, 1.00] |